Willingness to pay for booster dose of COVID-19 vaccine among healthcare workers in Taizhou,China

Pan, Shuang-Jun; Yang, Yupei; Zhang, Meixian; Tung, Tao‐Hsin

doi:10.1080/21645515.2022.2063629

Cited by 9 publications

(10 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Variability in WTP for the primary COVID-19 vaccination has been reported in different studies globally [ 17 , 48 , 49 , 50 , 51 , 52 , 53 ]; however, our study can be considered among the first studies to assess WTP for the booster dose of the vaccine. A recent study that was conducted among HCWs in China showed that the WTP for the booster dose was reported among only 47% of the participants [ 14 ].…”

Section: Discussionmentioning

confidence: 99%

“…Originally derived from the economic literature, WTP was later adopted in various disciplines, particularly to assess judgment in making decisions [ 13 ], in this case, the decision to receive a booster dose vaccine or not. Booster dose vaccine WTP research is still scarce and under studied; as far as we know, research on booster dose WTP has only been initiated in China [ 11 , 14 , 15 ]. Although these studies found that booster dose vaccines are widely accepted in China (nearly 85%), the WTP was generally low, with individuals willing to pay less than 200 Chinese Yuan Renminbi (CNY), i.e., around USD 28.49, and refusing to pay more [ 11 ].…”

Section: Introductionmentioning

confidence: 99%

“…Although these studies found that booster dose vaccines are widely accepted in China (nearly 85%), the WTP was generally low, with individuals willing to pay less than 200 Chinese Yuan Renminbi (CNY), i.e., around USD 28.49, and refusing to pay more [ 11 ]. Another survey study found that only 14.5% (155/1072) of healthcare workers (HCWs) were willing to pay 100 CNY (equivalent to USD 14.25) for a booster vaccine, while 53% were unwilling to pay [ 14 ]. Sociodemographic, individual attitudes, and beliefs are factors that greatly affect booster dose vaccine acceptance and the WTP for booster doses [ 11 , 16 , 17 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia

Harapan

Sallam

Fathima

et al. 2022

Infectious Disease Reports

View full text Add to dashboard Cite

Willingness to pay (WTP) for booster doses of coronavirus disease 2019 (COVID-19) vaccines is an under studied research topic. Therefore, the current study aimed to investigate the WTP for the booster doses of COVID-19 vaccines and its predictors in Indonesia using an online survey distributed all over the provinces of this low-middle-income country. The WTP was evaluated using a basic dichotomous contingent valuation approach, and its associated determinants were evaluated using a linear regression model. Out of 2935 responders, 66.2% (1942/2935) were willing to pay for a booster dose of the COVID-19 vaccine. The majority of respondents (63.5%) were willing to pay within a price range of 100,000–500,000 Indonesian rupiah (IDR), i.e., USD 6.71–33.57. Being older than 40 years, having a higher educational level, having a higher income, knowing and understanding that booster doses were important, and having a vaccine status that is certified halal (permissible in Islamic law), were all associated with a higher WTP for the booster dose of COVID-19 vaccines. The study findings imply that the WTP for a booster dose of COVID-19 vaccination in Indonesia is lower compared to acceptance of vaccines provided free of charge. This WTP data can be utilized to develop a pricing scheme for the booster doses of COVID-19 vaccination in the country with potential benefits in other low-income countries. The government may be required to provide subsidies for the herd immunity vaccination process to proceed as anticipated. Furthermore, the public community must be educated on the importance of vaccination as well as the fact that the COVID-19 epidemic is far from being over.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia

Harapan

Sallam

Fathima

et al. 2022

Infectious Disease Reports

View full text Add to dashboard Cite

show abstract

“…A booster vaccination is essential to supplement the decreasing protective efficacy of the vaccine against the emergence of mutated strains, which, in turn, would protect the vulnerable elderly disease populations from infection and development of severe disease and would reduce the socioeconomic burden. Moreover, a booster dose of COVID-19 vaccine re-enforces individual immune responses in the elderly population and enhances the protective effect of the vaccine against a variety of COVID-19 variants, including Delta variant strains [ 13 , 14 , 15 ], providing a scientific basis for booster vaccination. In the process of promoting COVID-19 vaccine booster doses in various countries, older adults over 60 years of age and people with comorbid underlying diseases are the priority groups currently recommended for booster vaccination.…”

Section: Introductionmentioning

confidence: 99%

“…There are few studies on the willingness to receive the COVID-19 vaccine booster that have focused on the population of older adults with chronic diseases; studies have mostly been focused on the general adult population and healthcare workers [ 13 , 14 ]. Questionnaires have also been widely used as a research method in previous studies on the intention to vaccinate the elderly with the initial doses of the COVID-19 vaccine.…”

Section: Introductionmentioning

confidence: 99%

Willingness of Older Adults with Chronic Diseases to Receive a Booster Dose of Inactivated Coronavirus Disease 2019 Vaccine: A Cross-Sectional Study in Taizhou, China

Lin

Zhang

et al. 2022

Vaccines

View full text Add to dashboard Cite

Vaccination is an important measure to control the spread of COVID-19 among elderly high-risk groups; however, the propensity to receive COVID-19 vaccine boosters has not been evaluated in these populations. Here, we aimed to investigate the willingness to receive a COVID-19 vaccine booster among the elderly chronic disease population in Taizhou, China. A cross-sectional, hospital-based survey was conducted in the outpatient department of a tertiary care hospital between 6 July and 11 August 2021 in Taizhou, China, and the data were uploaded to Wen-Juan-Xing, one of the largest online platforms used to collect survey data in China. The targeted population was non-oncology chronic disease patients aged 60 years and above. The minimum sample size was 229, determined by the G*Power software (v3.1.9.2, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany). A total of 254 patients with valid data were enrolled in this study, with a response rate of 82.5% (254/308). Chi-square tests and one-way binary regression were used to compare the proportions and the degree of influence of categorical factors. The magnitude of the effect for the comparisons was measured by Gramer’s V. A multivariate binary logistic regression model was used to correct for confounders and to identify factors. All data were analyzed using SPSS v24.0 (IBM Corporation, Armonk, NY, USA). A total of 198 respondents (77.9%) were willing to receive a COVID-19 vaccine booster dose, and 77.6% of respondents were willing to receive the primary dose. Age <70 years (OR 2.82), stable disease control (OR 2.79), confidence in the effectiveness of the COVID-19 vaccine (OR 3.11), and vaccine recipient (OR 5.02) were significantly associated with the willingness to receive a COVID-19 vaccine booster dose. Promoting primary dose vaccination is essential for advancing booster vaccination, and it is important to focus on elderly patients’ confidence in the vaccine, in addition to strengthening health management and promoting disease stability. Follow-up studies should focus on elderly patients who belong to specific disease groups.

show abstract

Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study

Yan,

Chen,

Nuermaimaiti

et al. 2023

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Hypertension, a prevalent chronic disease, has been associated with increased COVID-19 severity. To promote the COVID-19 booster vaccination of hypertensive patients, this study investigated the willingness to receive boosters and the related influencing factors based on the health belief model (HBM model). Between June and October 2022, 453 valid questionnaires were collected across three Chinese cities. The willingness to receive a booster vaccination was 72.2%. The main factors that influenced the willingness of patients with hypertension to receive a booster shot were male (χ 2 = 7.008, p = .008), residence in rural (χ 2 = 4.778, p = .029), being in employment (χ 2 = 7.232, p = .007), taking no or less antihypertensive medication (χ 2 = 9.372, p = .025), with less hypertension-related comorbidities (χ 2 = 35.888, p < .0001), and did not have any other chronic diseases (χ 2 = 28.476, p < .0001). Amid the evolving COVID-19 landscape, the willingness to receive annual booster vaccination was 59.4%, and employment status (χ 2 = 10.058, p = .002), and presence of other chronic diseases (χ 2 = 14.256, p < .0001) are associated with the willingness of annual booster vaccination. Respondents with higher perceived severity, perceived benefits, perceived self-efficacy, and lower perceived barriers were more willing to receive booster shots. The mean and median value of willingness to pay (WTP) for a dose of booster were 53.17 CNY and 28.31 CNY. Concerns regarding booster safety and the need for professional advice were prevalent. Our findings highlight the importance of promoting booster safety knowledge and health-related management among hypertensive individuals through professional organizations and medical specialists.

show abstract

Willingness to pay for booster dose of COVID-19 vaccine among healthcare workers in Taizhou,China

Cited by 9 publications

References 23 publications

Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia

Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia

Willingness of Older Adults with Chronic Diseases to Receive a Booster Dose of Inactivated Coronavirus Disease 2019 Vaccine: A Cross-Sectional Study in Taizhou, China

Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study

Contact Info

Product

Resources

About